Multiple normal/diseased tissues from 12 human tissue types, featuring a dual-core design, can serve as positive controls for over 90% of existing conventional pathological diagnostic antibodies, and are also suitable for screening and optimization of immunohistochemical or in situ hybridization antibodies/probes.